Similar articles for PMID: 23804073

Year	Number of Results
2002	1
2004	3
2005	4
2006	1
2007	1
2008	5
2009	7
2010	4
2011	12
2012	21
2013	22
2014	24
2015	27
2016	17
2017	19
2018	20
2019	19
2020	14
2021	18
2022	8
2023	1
2024	0

1

Modulation of TSC-mTOR signaling on immune cells in immunity and autoimmunity.

Yang H, Wang X, Zhang Y, Liu H, Liao J, Shao K, Chu Y, Liu G. Yang H, et al. J Cell Physiol. 2014 Jan;229(1):17-26. doi: 10.1002/jcp.24426. J Cell Physiol. 2014. PMID: 23804073 Review.

2

Role of TSC-mTOR pathway in diabetic nephropathy.

Inoki K. Inoki K. Diabetes Res Clin Pract. 2008 Nov 13;82 Suppl 1:S59-62. doi: 10.1016/j.diabres.2008.09.028. Epub 2008 Oct 15. Diabetes Res Clin Pract. 2008. PMID: 18926585 Review.

3

Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.

Lin CY, Hsu SC, Lee HS, Lin SH, Tsai CS, Huang SM, Shih CC, Hsu YJ. Lin CY, et al. J Vasc Surg. 2013 Feb;57(2):475-85. doi: 10.1016/j.jvs.2012.07.037. Epub 2012 Dec 21. J Vasc Surg. 2013. PMID: 23265586 Free article.

4

Tuberous sclerosis complex tumor suppressor-mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent.

Jaeschke A, Hartkamp J, Saitoh M, Roworth W, Nobukuni T, Hodges A, Sampson J, Thomas G, Lamb R. Jaeschke A, et al. J Cell Biol. 2002 Oct 28;159(2):217-24. doi: 10.1083/jcb.jcb.200206108. Epub 2002 Oct 28. J Cell Biol. 2002. PMID: 12403809 Free PMC article.

5

Tsc1 deficiency-mediated mTOR hyperactivation in vascular endothelial cells causes angiogenesis defects and embryonic lethality.

Ma A, Wang L, Gao Y, Chang Z, Peng H, Zeng N, Gui YS, Tian X, Li X, Cai B, Zhang H, Xu KF. Ma A, et al. Hum Mol Genet. 2014 Feb 1;23(3):693-705. doi: 10.1093/hmg/ddt456. Epub 2013 Sep 18. Hum Mol Genet. 2014. PMID: 24129405

6

Missense mutations to the TSC1 gene cause tuberous sclerosis complex.

Nellist M, van den Heuvel D, Schluep D, Exalto C, Goedbloed M, Maat-Kievit A, van Essen T, van Spaendonck-Zwarts K, Jansen F, Helderman P, Bartalini G, Vierimaa O, Penttinen M, van den Ende J, van den Ouweland A, Halley D. Nellist M, et al. Eur J Hum Genet. 2009 Mar;17(3):319-28. doi: 10.1038/ejhg.2008.170. Epub 2008 Oct 1. Eur J Hum Genet. 2009. PMID: 18830229 Free PMC article.

7

Direct activation of mTOR in B lymphocytes confers impairment in B-cell maturation andloss of marginal zone B cells.

Benhamron S, Tirosh B. Benhamron S, et al. Eur J Immunol. 2011 Aug;41(8):2390-6. doi: 10.1002/eji.201041336. Epub 2011 Jun 24. Eur J Immunol. 2011. PMID: 21674478 Free article.

8

Functional assessment of TSC2 variants identified in individuals with tuberous sclerosis complex.

Hoogeveen-Westerveld M, Ekong R, Povey S, Mayer K, Lannoy N, Elmslie F, Bebin M, Dies K, Thompson C, Sparagana SP, Davies P, van Eeghen AM, Thiele EA, van den Ouweland A, Halley D, Nellist M. Hoogeveen-Westerveld M, et al. Hum Mutat. 2013 Jan;34(1):167-75. doi: 10.1002/humu.22202. Epub 2012 Oct 11. Hum Mutat. 2013. PMID: 22903760

9

Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways.

Kwiatkowski DJ, Manning BD. Kwiatkowski DJ, et al. Hum Mol Genet. 2005 Oct 15;14 Spec No. 2:R251-8. doi: 10.1093/hmg/ddi260. Hum Mol Genet. 2005. PMID: 16244323 Review.

10

Mammalian target of rapamycin signaling in the podocyte.

Inoki K, Huber TB. Inoki K, et al. Curr Opin Nephrol Hypertens. 2012 May;21(3):251-7. doi: 10.1097/MNH.0b013e3283520f38. Curr Opin Nephrol Hypertens. 2012. PMID: 22388550 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

216 results

Results by year